| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Protease | 21 | 2021 | 120 | 3.800 |
Why?
|
| Drug Resistance, Viral | 24 | 2025 | 156 | 3.290 |
Why?
|
| HIV Protease Inhibitors | 15 | 2021 | 105 | 2.870 |
Why?
|
| Antiviral Agents | 20 | 2025 | 313 | 2.240 |
Why?
|
| Protease Inhibitors | 13 | 2023 | 104 | 1.830 |
Why?
|
| Models, Molecular | 34 | 2025 | 1128 | 1.720 |
Why?
|
| HIV-1 | 15 | 2021 | 692 | 1.380 |
Why?
|
| Viral Nonstructural Proteins | 12 | 2022 | 93 | 1.380 |
Why?
|
| Drug Design | 8 | 2022 | 136 | 1.270 |
Why?
|
| Molecular Dynamics Simulation | 17 | 2024 | 119 | 1.260 |
Why?
|
| Protein Binding | 35 | 2025 | 1555 | 1.180 |
Why?
|
| Catalytic Domain | 19 | 2025 | 193 | 1.080 |
Why?
|
| Protein Conformation | 22 | 2025 | 763 | 1.040 |
Why?
|
| Quinoxalines | 8 | 2022 | 35 | 1.020 |
Why?
|
| Mutation | 21 | 2025 | 2456 | 1.020 |
Why?
|
| DNA, Single-Stranded | 7 | 2021 | 100 | 1.010 |
Why?
|
| Peptides | 5 | 2013 | 549 | 0.970 |
Why?
|
| Crystallography, X-Ray | 22 | 2025 | 424 | 0.950 |
Why?
|
| Drug Resistance | 4 | 2024 | 95 | 0.940 |
Why?
|
| Hepatitis C | 4 | 2021 | 143 | 0.900 |
Why?
|
| Hepacivirus | 9 | 2022 | 140 | 0.850 |
Why?
|
| Models, Chemical | 3 | 2008 | 137 | 0.770 |
Why?
|
| Cytidine Deaminase | 5 | 2025 | 84 | 0.750 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2019 | 111 | 0.740 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 3 | 2020 | 35 | 0.720 |
Why?
|
| Protein Folding | 9 | 2014 | 260 | 0.670 |
Why?
|
| Sulfonamides | 7 | 2022 | 120 | 0.670 |
Why?
|
| Substrate Specificity | 14 | 2024 | 333 | 0.650 |
Why?
|
| Escherichia coli | 5 | 2021 | 695 | 0.600 |
Why?
|
| Apoproteins | 5 | 2011 | 18 | 0.580 |
Why?
|
| Darunavir | 6 | 2021 | 30 | 0.570 |
Why?
|
| Myoglobin | 5 | 2011 | 27 | 0.570 |
Why?
|
| Viral Proteins | 3 | 2025 | 253 | 0.560 |
Why?
|
| Leucine | 6 | 2025 | 61 | 0.540 |
Why?
|
| Proteins | 5 | 2018 | 730 | 0.520 |
Why?
|
| Enterovirus D, Human | 3 | 2025 | 10 | 0.510 |
Why?
|
| Cysteine Endopeptidases | 3 | 2025 | 92 | 0.500 |
Why?
|
| Structure-Activity Relationship | 9 | 2021 | 365 | 0.490 |
Why?
|
| Evolution, Molecular | 3 | 2014 | 298 | 0.490 |
Why?
|
| Proline | 5 | 2025 | 42 | 0.490 |
Why?
|
| Amino Acid Sequence | 12 | 2021 | 1553 | 0.490 |
Why?
|
| Binding Sites | 15 | 2019 | 881 | 0.480 |
Why?
|
| HIV Infections | 6 | 2020 | 913 | 0.480 |
Why?
|
| Enzyme Inhibitors | 3 | 2025 | 347 | 0.480 |
Why?
|
| Cyclopropanes | 5 | 2022 | 50 | 0.460 |
Why?
|
| Ribosomes | 2 | 2014 | 154 | 0.460 |
Why?
|
| Nelfinavir | 1 | 2014 | 7 | 0.450 |
Why?
|
| Serine Endopeptidases | 3 | 2022 | 84 | 0.440 |
Why?
|
| Thermodynamics | 10 | 2016 | 191 | 0.420 |
Why?
|
| Escherichia coli Proteins | 4 | 2013 | 264 | 0.410 |
Why?
|
| Aminoisobutyric Acids | 3 | 2022 | 9 | 0.400 |
Why?
|
| Lactams, Macrocyclic | 3 | 2022 | 25 | 0.390 |
Why?
|
| Dengue Virus | 2 | 2017 | 95 | 0.390 |
Why?
|
| Machine Learning | 4 | 2021 | 153 | 0.380 |
Why?
|
| DNA Helicases | 1 | 2013 | 187 | 0.370 |
Why?
|
| Humans | 44 | 2025 | 59390 | 0.370 |
Why?
|
| Peptide Chain Elongation, Translational | 2 | 2014 | 11 | 0.370 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2006 | 78 | 0.360 |
Why?
|
| Trans-Activators | 1 | 2013 | 300 | 0.360 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2020 | 10 | 0.350 |
Why?
|
| Molecular Docking Simulation | 6 | 2022 | 73 | 0.350 |
Why?
|
| APOBEC-3G Deaminase | 2 | 2020 | 21 | 0.340 |
Why?
|
| Polyproteins | 2 | 2016 | 8 | 0.320 |
Why?
|
| Protein Biosynthesis | 2 | 2013 | 297 | 0.300 |
Why?
|
| Peptide Hydrolases | 3 | 2023 | 78 | 0.300 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 33 | 0.300 |
Why?
|
| Globins | 3 | 2014 | 25 | 0.290 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2018 | 40 | 0.290 |
Why?
|
| Antibodies, Neutralizing | 2 | 2020 | 178 | 0.280 |
Why?
|
| Drug Discovery | 4 | 2021 | 89 | 0.270 |
Why?
|
| Static Electricity | 5 | 2021 | 163 | 0.260 |
Why?
|
| Dengue | 1 | 2016 | 92 | 0.260 |
Why?
|
| Serine Proteases | 3 | 2021 | 13 | 0.250 |
Why?
|
| Amino Acid Substitution | 4 | 2019 | 234 | 0.250 |
Why?
|
| APOBEC Deaminases | 2 | 2025 | 10 | 0.250 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2019 | 292 | 0.240 |
Why?
|
| RNA | 2 | 2019 | 401 | 0.240 |
Why?
|
| Mutation, Missense | 3 | 2019 | 172 | 0.240 |
Why?
|
| Cytidine | 3 | 2025 | 14 | 0.240 |
Why?
|
| Kinetics | 8 | 2018 | 751 | 0.240 |
Why?
|
| Cytosine | 1 | 2025 | 31 | 0.240 |
Why?
|
| Valine | 2 | 2021 | 31 | 0.230 |
Why?
|
| Protein Structure, Secondary | 8 | 2017 | 253 | 0.230 |
Why?
|
| Ribonucleoproteins | 1 | 2025 | 112 | 0.220 |
Why?
|
| Gene Products, pol | 1 | 2003 | 8 | 0.220 |
Why?
|
| Electrochemistry | 1 | 2003 | 27 | 0.220 |
Why?
|
| Gene Products, gag | 1 | 2003 | 63 | 0.210 |
Why?
|
| Flavivirus | 1 | 2022 | 8 | 0.200 |
Why?
|
| Amino Acids | 2 | 2018 | 140 | 0.200 |
Why?
|
| Furans | 2 | 2020 | 33 | 0.200 |
Why?
|
| Zika Virus | 1 | 2022 | 32 | 0.200 |
Why?
|
| Zika Virus Infection | 1 | 2022 | 32 | 0.200 |
Why?
|
| Computer Simulation | 5 | 2017 | 459 | 0.200 |
Why?
|
| Swine | 1 | 2023 | 354 | 0.190 |
Why?
|
| Pyrrolidinones | 1 | 2021 | 11 | 0.190 |
Why?
|
| Isoxazoles | 1 | 2021 | 12 | 0.190 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 21 | 0.190 |
Why?
|
| Phenylalanine | 1 | 2021 | 25 | 0.190 |
Why?
|
| Macrocyclic Compounds | 1 | 2021 | 8 | 0.190 |
Why?
|
| Mammals | 1 | 2023 | 209 | 0.190 |
Why?
|
| Drug Resistance, Fungal | 1 | 2021 | 10 | 0.190 |
Why?
|
| Pneumocystis carinii | 1 | 2021 | 7 | 0.190 |
Why?
|
| Subtilisin | 1 | 2001 | 1 | 0.180 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2021 | 5 | 0.180 |
Why?
|
| Pandemics | 2 | 2023 | 617 | 0.180 |
Why?
|
| Herbicides | 1 | 2021 | 18 | 0.180 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2021 | 30 | 0.180 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 333 | 0.180 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 89 | 0.180 |
Why?
|
| Gene Editing | 1 | 2025 | 299 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 42 | 0.170 |
Why?
|
| Pesticides | 1 | 2021 | 55 | 0.170 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 1951 | 0.170 |
Why?
|
| Virus Diseases | 1 | 2021 | 114 | 0.170 |
Why?
|
| Peptide Fragments | 3 | 2014 | 400 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 94 | 0.170 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 95 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 656 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 117 | 0.160 |
Why?
|
| Epitopes | 2 | 2020 | 286 | 0.160 |
Why?
|
| Epistasis, Genetic | 1 | 2019 | 42 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 143 | 0.160 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 34 | 0.150 |
Why?
|
| Influenza A Virus, H7N9 Subtype | 1 | 2018 | 7 | 0.150 |
Why?
|
| Drug Resistance, Multiple, Viral | 1 | 2018 | 14 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 166 | 0.150 |
Why?
|
| Animals | 10 | 2025 | 19650 | 0.150 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 4 | 2018 | 256 | 0.150 |
Why?
|
| Hydrogen Bonding | 4 | 2021 | 125 | 0.150 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 33 | 0.150 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2017 | 58 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 176 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 91 | 0.140 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 20 | 0.140 |
Why?
|
| Benzimidazoles | 1 | 2017 | 54 | 0.140 |
Why?
|
| Amino Acid Motifs | 3 | 2018 | 149 | 0.140 |
Why?
|
| Carbamates | 4 | 2020 | 25 | 0.140 |
Why?
|
| Neuraminidase | 1 | 2016 | 43 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 57 | 0.130 |
Why?
|
| Protein Denaturation | 3 | 2019 | 67 | 0.130 |
Why?
|
| Lipoproteins | 1 | 2016 | 80 | 0.130 |
Why?
|
| Entropy | 2 | 2014 | 21 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 836 | 0.130 |
Why?
|
| Borrelia burgdorferi | 1 | 2016 | 68 | 0.130 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 87 | 0.130 |
Why?
|
| Antigens, Surface | 1 | 2016 | 192 | 0.130 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2016 | 121 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 217 | 0.130 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 292 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2025 | 587 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 628 | 0.120 |
Why?
|
| Molecular Structure | 3 | 2021 | 374 | 0.120 |
Why?
|
| Influenza A virus | 1 | 2016 | 116 | 0.120 |
Why?
|
| Lyme Disease | 1 | 2016 | 104 | 0.120 |
Why?
|
| Enterovirus Infections | 2 | 2025 | 11 | 0.120 |
Why?
|
| Lactams | 2 | 2025 | 18 | 0.120 |
Why?
|
| DNA | 1 | 2019 | 805 | 0.120 |
Why?
|
| Genotype | 1 | 2016 | 617 | 0.110 |
Why?
|
| Archaea | 1 | 2014 | 9 | 0.110 |
Why?
|
| Nitriles | 2 | 2025 | 62 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1151 | 0.110 |
Why?
|
| Water | 4 | 2019 | 300 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2021 | 2900 | 0.110 |
Why?
|
| Amides | 3 | 2020 | 52 | 0.110 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 153 | 0.090 |
Why?
|
| Neoplasms | 1 | 2021 | 1231 | 0.090 |
Why?
|
| Ligands | 2 | 2019 | 411 | 0.080 |
Why?
|
| Plant Proteins | 2 | 2001 | 81 | 0.080 |
Why?
|
| Orthomyxoviridae | 2 | 2021 | 26 | 0.080 |
Why?
|
| Biocatalysis | 2 | 2019 | 45 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 83 | 0.080 |
Why?
|
| Deamination | 2 | 2019 | 10 | 0.080 |
Why?
|
| Protein Domains | 2 | 2020 | 140 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2008 | 184 | 0.070 |
Why?
|
| Dihydropteridine Reductase | 1 | 2007 | 1 | 0.070 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2007 | 18 | 0.070 |
Why?
|
| Hemeproteins | 1 | 2007 | 16 | 0.070 |
Why?
|
| Computational Biology | 2 | 2021 | 333 | 0.070 |
Why?
|
| Zinc | 2 | 2020 | 91 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2017 | 356 | 0.070 |
Why?
|
| Urea | 1 | 2005 | 35 | 0.060 |
Why?
|
| Solvents | 1 | 2005 | 57 | 0.060 |
Why?
|
| Indoles | 1 | 2025 | 106 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2025 | 61 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 2 | 2016 | 100 | 0.060 |
Why?
|
| Microsomes | 1 | 2013 | 11 | 0.050 |
Why?
|
| Energy Transfer | 1 | 2003 | 9 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2003 | 46 | 0.050 |
Why?
|
| Motion | 1 | 2003 | 56 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2025 | 215 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 160 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2003 | 359 | 0.050 |
Why?
|
| Halogenation | 1 | 2022 | 4 | 0.050 |
Why?
|
| Fluorine | 1 | 2022 | 9 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2018 | 450 | 0.050 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2021 | 15 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 88 | 0.040 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2020 | 22 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 76 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 127 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 121 | 0.040 |
Why?
|
| Dipeptides | 1 | 2020 | 60 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2025 | 697 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 574 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 228 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 1999 | 88 | 0.040 |
Why?
|
| Methionine | 1 | 2019 | 53 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2024 | 540 | 0.040 |
Why?
|
| Sperm Whale | 2 | 2011 | 3 | 0.040 |
Why?
|
| Virion | 1 | 2019 | 119 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 446 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2018 | 68 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 259 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2017 | 11 | 0.040 |
Why?
|
| Time Factors | 2 | 2005 | 3618 | 0.040 |
Why?
|
| Mice | 2 | 2025 | 10291 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2017 | 100 | 0.040 |
Why?
|
| Rats | 1 | 2021 | 1910 | 0.040 |
Why?
|
| Proteolysis | 1 | 2018 | 136 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2017 | 147 | 0.040 |
Why?
|
| Aprotinin | 1 | 2017 | 12 | 0.040 |
Why?
|
| Surface Properties | 1 | 2018 | 271 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 234 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 288 | 0.030 |
Why?
|
| Zanamivir | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 381 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2016 | 20 | 0.030 |
Why?
|
| Oseltamivir | 1 | 2016 | 34 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 248 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 689 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 144 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 809 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 620 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2016 | 192 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 1143 | 0.030 |
Why?
|
| Atazanavir Sulfate | 1 | 2013 | 2 | 0.030 |
Why?
|
| Calorimetry | 1 | 2012 | 40 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 103 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2013 | 128 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 160 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 98 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 177 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 46 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 253 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 90 | 0.020 |
Why?
|
| Protein Renaturation | 1 | 2005 | 4 | 0.020 |
Why?
|
| Buffers | 1 | 2005 | 23 | 0.020 |
Why?
|
| Chromatography | 1 | 2005 | 16 | 0.020 |
Why?
|
| Biophysics | 1 | 2005 | 41 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2005 | 72 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2005 | 107 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 133 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 247 | 0.010 |
Why?
|
| Light | 1 | 2005 | 198 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 295 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 299 | 0.010 |
Why?
|
| Male | 1 | 2021 | 27750 | 0.010 |
Why?
|